Publications by authors named "Deborah van de Wal"

Claim this Profile
P
Patient-physician agreement on function and pain is associated with long-term outcomes in sarcoma: findings from a longitudinal study.
Urška Košir, Deborah van de Wal, Olga Husson, Nadine Zablith, Robert E Turcotte

J Cancer Surviv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study.
Deborah van de Wal, Dide den Hollander, Ingrid M E Desar, Hans Gelderblom, Astrid W Oosten

Support Care Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the interconnectedness between health-related quality of life factors among long-term adolescent and young adult cancer survivors (AYAs): a network analysis.
Tom I Bootsma, Deborah van de Wal, Carla Vlooswijk, Daniëlle C Roos, Cas Drabbe

Support Care Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter study.
Deborah van de Wal, Dide den Hollander, Ingrid M E Desar, Hans Gelderblom, Astrid W Oosten

Int J Clin Health Psychol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GISTs) is Effective and Safe: Results from a Prospective Single-Center Study with 108 Patients.
Stijn J C van der Burg, Deborah van de Wal, Evelyne Roets, Neeltje Steeghs, Johanna W van Sandick

Ann Surg Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of having a monitoring or blunting coping style with psychological distress, health-related quality of life and satisfaction with healthcare in gastrointestinal stromal tumour (GIST) patients.
Deborah van de Wal, Britt van Doorn, Dide den Hollander, Ingrid M E Desar, Hans Gelderblom

Acta Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological and social challenges of patients with locally advanced and metastatic gastrointestinal stromal tumours (GIST) on long-term treatment with tyrosine kinase inhibitors: a qualitative study with patients and medical oncologists.
Deborah van de Wal, Lena Fauske, Øyvind S Bruland, Robin L Jones, Bernd Kasper

Support Care Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient's perspective on the side effects of tyrosine kinase inhibitors in the treatment of advanced and metastatic gastrointestinal stromal tumors.
Deborah van de Wal, Shreenila Venkatesan, Charlotte Benson, Winette TA van der Graaf, Colin D Johnson

Future Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching the scope from "how to identify cancer survivors" to "who is participating in cancer survivorship research": A proposal for a new focus.
Deborah van de Wal, Silvie H M Janssen, Daniël J van der Meer, Carla C P Vlooswijk, Daniëlle C Roos

Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature.
Deborah van de Wal, Mai Elie, Axel Le Cesne, Elena Fumagalli, Dide den Hollander

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis